Recent Updates
Recently added Catalysts
BVS Positive Sentiment Score: 75/100

Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference

Tuesday, January 6, 2026 1 min read
Key Takeaway: Bioventus Inc. will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026. CEO Rob Claypoole is scheduled to deliver the presentation at 9:45 a.m. PT. The webcast will be accessible for a limited time on the company's investor website. Bioventus focuses on providing proven, cost-effective health solutions aimed at enhancing patient recovery and quality of life.

Market Sentiment Analysis

POSITIVE FACTORS

  • Bioventus is recognized as a global leader in innovations for active healing.
  • The company is committed to delivering cost-effective products that aid in healing.
  • The presentation at a major healthcare conference highlights the company's visibility and engagement with the investment community.

Full Press Release Details

DURHAM, N.C., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 9:45 a.m. PT (12:45 p.m. ET).
The live webcast of the presentation, including Q&A, may be accessed on the Investors section of the Bioventus website and will be available for replay until February 14, 2026.
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
dave.crawford@bioventus.com

Frequently Asked Questions

When will Bioventus present at the J.P. Morgan Healthcare Conference?

Bioventus will present on January 14, 2026, at 9:45 a.m. PT.

Where can I access Bioventus' conference presentation?

The presentation can be accessed in the Investors section of Bioventus' website.

How long will the presentation replay be available?

The presentation replay will be available until February 14, 2026.

What are Bioventus' areas of focus?

Bioventus focuses on Pain Treatments, Restorative Therapies, and Surgical Solutions.

What values guide Bioventus' operations?

Bioventus is guided by high quality standards, evidence-based medicine, and ethics.

Tags: BVS Viatris Investor Conferences Healthcare Bioventus J.P. Morgan Conference active healing Rob Claypoole healthcare innovations
Last updated: Jan 6, 2026